Advertisement Lab Dom to roll out anti-aging therapies in Middle East - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lab Dom to roll out anti-aging therapies in Middle East

Lab Dom AVMM (Suisse), specialised in Swiss cell therapy, is set to introduce a range of anti-aging therapies, including MFIII of Switzerland PE Softgels Advanced Formula, a cellular therapy oral supplement, in the Middle East.

Lab Dom claims that it had invented the first cellular therapy oral supplement product in the world, using hi-tech softgel capsules that can preserve the complete bioactivity of the DNA cell extracts.

Procured from a certified closed-colony of sheep stringently maintained for more than 40 generations, the bioactive cellular materials embedded within the PE Softgels are pure and raw placenta extracts’ from the sheep, the company said.

MFIII Asia Pacific Regional Hub CEO Mike Chan was quoted by AMEinfo.com as saying that cell therapy involves the implantation of cells or extracts of fetal tissue into the human body.

"These young cells will thereafter stimulate the growth and function of existing tissue, awaken dormant cells, and repair old or malfunctioning cells," Chan said.